Department of Surgery, Knappschafts-Hospital, Ruhr-University Bochum, Bochum, Germany.
Transpl Int. 2011 Feb;24(2):136-42. doi: 10.1111/j.1432-2277.2010.01172.x. Epub 2010 Oct 13.
Aging of the population and improvements in diabetes therapy have led to an increased number of older pancreas transplant candidates. The aim of our retrospective study was to evaluate pancreas transplantation (PT) outcomes in patients ≥ 50 years, as limited data exist in these patients. We analyzed 398 consecutive pancreas transplant patients from June 1994 to June 2009 for different outcomes (patient/graft survival, rejection rate, and surgical complications) between the age groups ≥ 50 years (n = 69) and <50 years (n = 329). Donor and recipient characteristics were similar except for recipient age (54.0 vs. 38.8 years), BMI (24.6 vs. 22.9 kg/m(2) ), and duration of diabetes mellitus (36.0 vs. 27.7 years). One-, 5-, and 10-year patient and graft (kidney/pancreas) survival were not significantly different between the groups with patient survival rates reaching 84% and pancreas graft survival up to 67% after 10 years. Surgical complications such as relaparotomy rate (34% vs. 33%) or pancreas graft thrombosis (14% vs. 11%) as well as 1-year rejection rates (35% vs. 31%) were not significantly different. PT in selected patients aged ≥ 50 years resulted in survival comparable with that of younger patients. In conclusion, advanced age should no longer be considered as an exclusion criterion for PT. However, good medical assessment and careful patient selection are necessary.
人口老龄化和糖尿病治疗的进步导致了越来越多的老年胰腺移植候选者。我们回顾性研究的目的是评估≥50 岁患者的胰腺移植(PT)结果,因为这些患者的数据有限。我们分析了 1994 年 6 月至 2009 年 6 月期间 398 例连续胰腺移植患者的不同结局(患者/移植物存活率、排斥率和手术并发症),年龄≥50 岁(n=69)和<50 岁(n=329)。除了受体年龄(54.0 岁 vs. 38.8 岁)、BMI(24.6 公斤/米 2 vs. 22.9 公斤/米 2 )和糖尿病病程(36.0 岁 vs. 27.7 岁)外,供体和受体特征相似。两组患者和移植物(肾/胰腺)的 1、5 和 10 年存活率无显著差异,患者存活率达到 84%,10 年后胰腺移植物存活率高达 67%。手术并发症如再次剖腹手术率(34% vs. 33%)或胰腺移植物血栓形成率(14% vs. 11%)以及 1 年排斥率(35% vs. 31%)无显著差异。对年龄≥50 岁的选定患者进行 PT 治疗可获得与年轻患者相当的生存率。总之,高龄不应再作为 PT 的排除标准。然而,需要进行良好的医学评估和仔细的患者选择。